Atlas Trials

Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

Clinical trial NCT02959658 · COMPLETED

Trial details

NCT number
NCT02959658
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Progressive Multiple Sclerosis
Start date
2016-12-01
Primary completion
2019-12-21
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.